Close Menu

NEW YORK (GenomeWeb) – Invitae announced after the close of the market on Tuesday that it will sell 9 million shares of its common stock at $19.00 per share.

The public offering, which Invitae announced on Monday, is expected to close on or around March 8 and bring in $171.0 million in gross proceeds, the firm said.  

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The American Prospect writes that the pilot program to test the DNA of migrants could lead to more family separations.

An international commission is to develop a report on how researchers, clinicians, and regulators should evaluate the clinical applications of human germline genome editing.

The US Department of Agriculture presents a new blueprint for animal genomic research.

In Genome Research this week: repetitive element deletion linked to altered methylation and more in form of muscular dystrophy; human contamination in draft bacterial and archaeal genomes; and more.